GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Althea Group Holdings Ltd (OTCPK:AHGHF) » Definitions » Research & Development

Althea Group Holdings (Althea Group Holdings) Research & Development : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Althea Group Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Althea Group Holdings's Research & Development for the six months ended in Dec. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Althea Group Holdings Research & Development Historical Data

The historical data trend for Althea Group Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Althea Group Holdings Research & Development Chart

Althea Group Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development
- - - - -

Althea Group Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Althea Group Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Althea Group Holdings  (OTCPK:AHGHF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Althea Group Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Althea Group Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Althea Group Holdings (Althea Group Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Althea Group Holdings Ltd (OTCPK:AHGHF) » Definitions » Research & Development
Comparable Companies
ASX:IDT ASX:PXS ASX:HGV ASX:ECS ASX:BOD ASX:EPN ASX:ME1 ASX:MXC ASX:EXL ASX:BP8 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
AGH:Australia
Address
360 Elizabeth Street, Suite 2, Level 50, Melbourne, VIC, AUS, 3000
Website
https://www.althea.life
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, and Corporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into four geographic segments: Australia, the United Kingdom, Canada, and others. The company earns key revenue from Australia and through the sale of medicinal cannabis products.

Althea Group Holdings (Althea Group Holdings) Headlines

From GuruFocus

Peak partners with Boston Beer Company to develop, produce, and distribute cannabis-infused beverages in Canada

By PRNewswire PRNewswire • 09-01-2021